[1]
M. Stoynova, A. Shinkov, and R. Kovatcheva, “Current therapeutic options in active moderate-to-severe thyroid-associated ophthalmopathy”, AMB, vol. 50, no. 4, pp. 59–68, Dec. 2023, doi: 10.2478/AMB-2023-0045.